Tag results:
EMT
Endothelial Cell News
Seamless Genetic Recording of Transiently Activated Mesenchymal Gene Expression in Endothelial Cells during Cardiac Fibrosis
[Circulation] Genetic fate mapping results revealed that a subset of cardiac endothelial cells transiently expressed αSMA and Zeb1 during embryonic valve formation and transdifferentiated into mesenchymal cells through EndoMT.
Pulmonary Cell News
TGF-β-Mediated Epithelial–Mesenchymal Transition and Tumor-Promoting Effects in CMT64 Cells Are Reflected in the Transcriptomic Signature of Human Lung Adenocarcinoma
[Scientific Reports] Scientists demonstrated for the first time that TGF-β could elicit epithelial–mesenchymal transition in a mouse lung adenocarcinoma cell line.
Mammary Cell News
Evolution of HER2-Positive Mammary Carcinoma: HER2 Loss Reveals Claudin-Low Traits in Cancer Progression
[Oncogenesis] Researchers studied cell lines derived from two transgenic mammary tumors driven by human HER2 that showed different dynamics of HER2 status. A dynamic model of HER2 status could lead to the identification of new druggable targets to counteract the resistance to HER2-targeted therapy caused by HER2 loss.
Cancer Stem Cell News
Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of...
[Cancers] Researchers showed that inhibition of RAC1 activation attenuated pluripotency marker expression and self-renewal ability, while depletion of RAC1b dramatically enhanced stemness features and clonogenic potential.
Endothelial Cell News
Role of Angiogenesis in Beta-Cell Epithelial–Mesenchymal Transition in Chronic Pancreatitis-Induced Diabetes
[Laboratory Investigation] Researchers suggested that angiogenesis promoted beta-cell survival in the inflamed pancreas, while suppression of angiogenesis turned beta-cell epithelial–mesenchymal transition into apoptotic beta-cell death.
Prostate Cell News
ISL1 Promotes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (CRPC) through Epithelial to Mesenchymal Transition (EMT)
[Scientific Reports] The authors revealed the important role of insulin gene enhancer-binding protein 1 (ISL1) in androgen receptor (AR)-dependent prostate cancer cell growth; ISL1 knockdown reduced the AR activity and cell growth.